Answers are grounded in this paper and cite their sources.
Observational study links chitinase-3-like protein 1 to stunting in HIV-exposed, uninfected children, suggesting a potential biomarker for growth issues.
Chronic systemic inflammation may affect linear growth and neurodevelopment in children who are HIV exposed but uninfected (cHEU). We examined plasma concentrations of neutrophil activation marker chitinase-3-like protein 1 (CHI3L1) levels in 153 Ugandan cHEU. At 18 months of age, CHI3L1 levels were inversely correlated with height-for-age z-scores (τB = -0.17, p=0.0035) and a normalized developmental score (τB = -0.20, p=0.00027). CHI3L1 appears to be a marker of adverse growth and development in cHEU.
No takes yet. Share an insight, caveat, or question.
MacBain et al. (2027) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: